D.E. Shaw & Co’s Delcath Systems DCTH Stock Holding History

D.E. Shaw & Co’s Portfolio DCTH Stock Details DCTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16,352	Closed	-$222K	–	4622
2025 Q2	$222K	Buy	+16,352	New	+$228K	﹤0.01%	4017

Other funds holding DCTH

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

D.E. Shaw & Co's DCTH Position: Q3 2025 in Review

D.E. Shaw & Co sold out of Delcath Systems (DCTH) in Q3 2025, closing a stake of 16,352 shares — an estimated $222K sold.

D.E. Shaw & Co first reported a position in DCTH in Q2 2025 and held it in 1 quarter. The position peaked at $222K in Q2 2025. 124 funds tracked by Wall St. Rank hold DCTH as of Q3 2025.

D.E. Shaw & Co reported no remaining Delcath Systems position as of Q3 2025 after selling out during the quarter.
D.E. Shaw & Co sold 16,352 Delcath Systems shares in Q3 2025, an estimated $222K.
D.E. Shaw & Co first reported a position in Delcath Systems in Q2 2025 and held it in 1 quarter.
D.E. Shaw & Co's Delcath Systems position peaked at $222K in Q2 2025.
124 funds tracked by Wall St. Rank held Delcath Systems as of Q3 2025.

Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.